Modugno P
Arch Sci Med (Torino). 1983 Apr-Jun;140(2):159-64.
It has been confirmed that epsilon-aminocaproic acid (EACA), an inhibitor of fibrinolysis, reduced the incidence of fat embolism in the lung of rabbits with experimental bone fractures. Microscopic specimens of lungs, examined under polarized light, demonstrated the reduced amounts of lipoid materials that were prevalently undergraded. The action of the drug is owed to the inhibition of some primary mechanisms, involved in the genesis and diffusion of post-traumatic fat embolism.
已经证实,纤溶抑制剂ε-氨基己酸(EACA)可降低实验性骨折家兔肺部脂肪栓塞的发生率。在偏光下检查的肺组织显微镜标本显示,普遍降解的类脂物质数量减少。该药物的作用归因于对创伤后脂肪栓塞发生和扩散所涉及的一些主要机制的抑制。